NEUROCRINE BIOSCIENCES INC
|
4,777,254
|
$587,363,000
|
15.71%
|
+62,004
|
+$124,137,000
|
AMICUS THERAPEUTICS, INC.
|
20,694,424
|
$250,196,000
|
6.69%
|
+670,000
|
-$62,586,000
|
Global Blood Therapeutics, Inc.
|
5,148,910
|
$195,658,000
|
5.23%
|
+320,000
|
-$22,608,000
|
ZOGENIX, INC.
|
3,807,632
|
$188,858,000
|
5.05%
|
-162,725
|
+$13,369,000
|
Solid Biosciences Inc.
|
3,927,222
|
$185,286,000
|
4.95%
|
-50,000
|
+$43,578,000
|
ALNYLAM PHARMACEUTICALS, INC.
|
1,197,994
|
$104,848,000
|
2.80%
|
-648,917
|
-$77,054,000
|
ACCELERON PHARMA INC
|
1,528,205
|
$87,459,000
|
2.34%
|
No Change
|
+$13,310,000
|
LA JOLLA PHARMACEUTICAL CO
PAR $.0001 2
|
4,313,611
|
$86,833,000
|
2.32%
|
New
|
+$86,833,000
|
IOVANCE BIOTHERAPEUTICS, INC.
|
7,290,199
|
$82,014,000
|
2.19%
|
+1,437,997
|
+$7,106,000
|
Ascendis Pharma A/S
SPONSORED ADR
|
1,072,647
|
$76,008,000
|
2.03%
|
No Change
|
+$4,656,000
|
Crinetics Pharmaceuticals, Inc.
|
2,587,953
|
$74,144,000
|
1.98%
|
New
|
+$74,144,000
|
Blueprint Medicines Corp
|
941,147
|
$73,466,000
|
1.96%
|
-20,000
|
+$12,452,000
|
MyoKardia, Inc.
|
1,089,169
|
$71,014,000
|
1.90%
|
No Change
|
+$16,936,000
|
DBV Technologies S.A.
SPONSORED ADR
|
3,009,998
|
$67,604,000
|
1.81%
|
New
|
+$67,604,000
|
Quotient Ltd
|
8,789,054
|
$66,357,000
|
1.77%
|
+2,306,034
|
+$14,299,000
|
DOVA PHARMACEUTICALS INC
|
3,125,851
|
$65,549,000
|
1.75%
|
No Change
|
-$27,976,000
|
MeiraGTx Holdings plc
|
4,703,398
|
$63,966,000
|
1.71%
|
No Change
|
+$10,066,000
|
ARENA PHARMACEUTICALS INC
|
1,366,978
|
$62,908,000
|
1.68%
|
+525,000
|
+$26,198,000
|
MERIT MEDICAL SYSTEMS INC
|
994,198
|
$61,093,000
|
1.63%
|
-87,815
|
+$5,694,000
|
Retrophin, Inc.
|
3,212,871
|
$60,483,000
|
1.62%
|
No Change
|
+$3,096,000
|
CORIUM INTERNATIONAL INC
|
6,357,133
|
$60,456,000
|
1.62%
|
No Change
|
+$9,535,000
|
Alector, Inc.
|
1,704,330
|
$56,175,000
|
1.50%
|
No Change
|
-$4,329,000
|
Verrica Pharmaceuticals Inc.
|
3,410,412
|
$55,419,000
|
1.48%
|
No Change
|
-$11,868,000
|
CytomX Therapeutics, Inc.
|
2,661,715
|
$49,242,000
|
1.32%
|
+740,000
|
+$5,312,000
|
Athenex, Inc.
|
2,869,528
|
$44,592,000
|
1.19%
|
+2,679,528
|
+$41,047,000
|